As mentioned in our last report, Gritstone Bio (GRTS) initially applied its next-generation heterologous (virus/sa-mRNA) vaccine technology to fight cancer. The thesis articulated by the founding … [Read more...] about Gritstone Bio (GRTS) Makes History in a Historically Hopeless Setting
Gritstone Oncology
Gritstone Oncology (Nasdaq: GRTS) Investment Update
Here we reflect on the past quarter for GRTS. Subsequent to the Phase 1a/1b data update on 7/14/20 GRTS lost 50% of its market capitalization ($155M) in a single day with ~30% of outstanding … [Read more...] about Gritstone Oncology (Nasdaq: GRTS) Investment Update
You must be logged in to post a comment.